Metallothionein and Innate Activation of Primary Human and Mouse Monocytes

  • James Koropatnick
  • Suzanne Dale
  • Rudolfs K. Zalups


Zinc Deficiency Respiratory Burst Zinc Treatment Primary Monocyte Luminol Chemiluminescence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. B, W.A., Pedersen, M.M., Mahajan, S.K., Sillix, D.H., Prasad, A.S., and McDonald, F.D. (1982). Lymphocyte and granulocyte function in zinc-treated and zinc-deficient hemodialysis patients. Kid Int. 21, 827–832.CrossRefGoogle Scholar
  2. Chvapil, M., Stankova, L., Zukoski IV, C., and Zukoski III, C. (1977). Inhibition of some functions of polymorphonuclear Leukocytes by in vitro zinc. J. Lab. Clin. Med. 89, 135–141.PubMedGoogle Scholar
  3. Kazimierczak, W. and Maslinski, C. (1974). Histamine release from mast cells by compound 48/80. The membrane action of zinc. Agents Actions 4, 320–323.CrossRefGoogle Scholar
  4. Kiremidjian-Schumacher, L., Stotzky, G., Likkite, V., Schwartz, J., and Dickstein, R.A. (1981). Influence of cadmium, lead and zinc on the ability of guinea pig macrophages to interact with macrophage migration inhibitory factor. Env. Res. 24, 106–116.CrossRefGoogle Scholar
  5. Koropatnick, J. and Zalups, R.K. (1997). Effect of non-toxic mercury, zinc or cadmium pretreatment on the capacity of human monocytes to undergo lipopolysaccharide-induced activation. Br. J. Pharmacology 120, 797–806.CrossRefGoogle Scholar
  6. Leibbrandt, M.E.I., Khokha, R., and Koropatnick, J. (1994). Antisense down-regulation of metallothionein in a human monocytic cell line alters anherence, invasion, and the respiratory burst. Cell Growth Differ. 5, 17–25.PubMedGoogle Scholar
  7. Leibbrandt, M.E.I, and Koropatnick, J. (1994). Activation of human monocytes with lipopolysaccharide induces metallothionein expression and is diminished by zinc. Toxicol. Appl. Pharmacol. 124, 72–81.CrossRefGoogle Scholar
  8. Marone, G. et al. (1981). Modulation of histamine release from human basophils in vitro by physiological concentrations of zinc. J. Pharmacol. Exp. Ther. 217, 202–298.Google Scholar
  9. Masters, B.A. et al. (1994). Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc. Nat’l Acad. Sci. (USA) 91, 584–588.CrossRefGoogle Scholar
  10. Nakamura, T., Shiraishi, N., and Aono, K. (1987). Effects of in vitro and in vivo supplementation with zinc on superoxide anion production in leukocytes. Physiol. Chem. Phys. Med. NMR 19, 147–151.PubMedGoogle Scholar
  11. Sozzani, P. et al. (1995). Interleukin-13 inhibits protein kinase C-triggered respiratory burst in human monocytes. Role of calcium and cyclic AMP. J. Biol Chem. 270, 5084–5088.CrossRefGoogle Scholar
  12. Vruwink, K.G., Fletcher, M.P., Keen, C.L., Golub, M.S., Hendrickx, A.G., and Gershwin, M.E. (1991). Moderate zinc deficiency in rhesus monkeys. An intrinsic defect on neutrophil chemotaxis. J. Immunol. 146, 244–249 (1991).PubMedGoogle Scholar
  13. Wirth, J.J., Fraker, P.J., and Kierszenbaum, F. (1989). Zinc requirement for macrophage function: effect of zinc deficiency on uptake and killing of a protozoan parasite. Immunol. 68, 114–119.Google Scholar
  14. ZENG, J. et al. (1991). Zinc transfer from transcription factor IIIA fingers to thionein clusters. Proc. Nat’l Acad. Sci. (USA) 90, 8013–8017.Google Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • James Koropatnick
    • 1
    • 2
  • Suzanne Dale
    • 2
  • Rudolfs K. Zalups
    • 3
  1. 1.Cancer Research LaboratoriesLondon Regional Cancer CentreLondonCanada
  2. 2.University of Western OntarioLondonCanada
  3. 3.Mercer University School of MedicineMaconUSA

Personalised recommendations